45:I[185,["/_next/static/chunks/08z4tkzvltetr.js","/_next/static/chunks/121~yigv24_j6.js","/_next/static/chunks/0a~e7k..h6jfc.js","/_next/static/chunks/0za7dr7c2y81~.js","/_next/static/chunks/03klviw01y.ih.js","/_next/static/chunks/0gx_3vy1-syt4.js","/_next/static/chunks/0i6hzvr84kc1r.js"],"SendEmailButton"] 4b:I[45269,["/_next/static/chunks/08z4tkzvltetr.js","/_next/static/chunks/121~yigv24_j6.js","/_next/static/chunks/0a~e7k..h6jfc.js","/_next/static/chunks/0za7dr7c2y81~.js","/_next/static/chunks/03klviw01y.ih.js","/_next/static/chunks/0gx_3vy1-syt4.js","/_next/static/chunks/0i6hzvr84kc1r.js"],"SignupCTA"] 3e:["$","span",null,{"aria-hidden":true,"children":"·"}] 3f:["$","span",null,{"children":"00:41:05"}] 46:T4f6,

The boys are back—new (temporary) studio, same no-BS approach.

Dr. Ken Brown and Eric Rieger dive deep into the unexpected resurgence of GLP-1 medications like Ozempic and Wegovy—this time, with a controversial twist: microdosing. Is less actually more? Can tiny doses of these peptides do more than just shed pounds? Think anxiety relief, autoimmune improvement, and possibly ditching antidepressants altogether. 🤯

In this episode, you’ll learn:

Why the original weight-loss hype may have missed the mark
The shocking mental health benefits patients are reporting
How the gut-brain axis could be the key to mood, metabolism & more
The dark side of big doses: muscle loss, acid reflux, thyroid risks, and sky-high costs
Why doctors are thinking outside the FDA box—and what it could mean for you

Whether you’ve tried these meds, are skeptical, or are just here for the banter, this episode blends science, sarcasm, and some serious truth bombs.

🎧 Tap play. This one’s for anyone who’s tired of one-size-fits-all medicine and wants to explore the future of gut-driven wellness.

47:T632,